Can PSA derivatives reduce unnecessary prostate MRI after negative biopsy? Learn how simple markers may guide imaging ...
In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...
Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.
Model was developed from the prostate cancer screening group of the PLCO and validated externally in a VA population ...
In this cohort study, a novel prognostic model was developed to estimate prostate cancer-specific mortality (PCSM) while ...
People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...
The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...
IsoPSA test offers improved prostate cancer risk stratification by analyzing PSA protein isoforms, enhancing specificity over traditional PSA tests. The test is included in key diagnostic guidelines, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback